Clinical Trial Update: Efficacy and Safety of Gabapentin in Treating Overactive Bladder [Phase 2, Phase 3]

View source ↗

Summary

Gabapentin for overactive bladder has completed Phase 2 and Phase 3 trials assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Michael E. Chua | Conditions: Urinary Urgency, Urinary Frequency | Phase 2, Phase 3 | Status: COMPLETED